Results 151 to 160 of about 2,720 (166)

Relebactam. Beta-lactamase inhibitor

Drugs of the Future, 2015
openaire   +1 more source

Aztreonam in combination with imipenem-relebactam against clinical and isogenic strains of serine and metallo-β-lactamase-producing enterobacterales

Diagnostic Microbiology and Infectious Disease, 2022
Mark Biagi, Rodrigo Mendes, Lalitagauri Deshpande   +2 more
exaly  

Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing Enterobacteriaceae

Antimicrobial Agents and Chemotherapy, 2018
Robert Bonomo, KRISZTINA Papp-Wallace
exaly  

Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects

Antimicrobial Agents and Chemotherapy, 2018
Elizabeth Rhee, Sheng Bi, Mark H Gotfried   +2 more
exaly  

Imipenem monohydrate/cilastatin sodium/relebactam monohydrate, pretomanid, and elexacaftor/tezacaftor/ivacaftor

Journal of the American Pharmacists Association, 2020
Daniel A, Hussar, Elias B, Chahine
openaire   +2 more sources

In vitro dynamics and mechanisms of resistance development to imipenem and imipenem/relebactam in Pseudomonas aeruginosa

Journal of Antimicrobial Chemotherapy, 2020
Bartolome Moya, Antonio Oliver, CARLOS Juan   +2 more
exaly  

Activity of imipenem/relebactam against Pseudomonas aeruginosa with antimicrobial-resistant phenotypes from seven global regions: SMART 2015–2016

Journal of Global Antimicrobial Resistance, 2018
Katherine Young, James Karlowsky, Sibylle Lob   +2 more
exaly  

Effect of Porins and bla KPC Expression on Activity of Imipenem with Relebactam in Klebsiella pneumoniae : Can Antibiotic Combinations Overcome Resistance?

Microbial Drug Resistance, 2018
John Quale, David Landman
exaly  

In Vitro Activity of Imipenem-Relebactam against Gram-Negative ESKAPE Pathogens Isolated by Clinical Laboratories in the United States in 2015 (Results from the SMART Global Surveillance Program)

Antimicrobial Agents and Chemotherapy, 2017
Katherine Young, James Karlowsky, Sibylle Lob   +2 more
exaly  

In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015–2016

European Journal of Clinical Microbiology and Infectious Diseases, 2019
Irène Galani, Ilias Karaiskos, Helen Giamarellou   +2 more
exaly